Inhibition of collagen breakdown by diphenylhydantoin.
Gingival tissue obtained from diphenylhydantoin-treated patients was cultured in the presence of [14C]proline for 24 h. The radioactive medium was removed and the tissue cultured for three days more. DNA, protein, hydroxyproline, proline and radioactivity determinations in the tissue indicated increased cellular proliferation, increased collagen contents and decreased breakdown of collagen in the affected tissues. The media were assayed for dialyzable and non-dialyzable hydroxyproline contents. It was found that the media in which diphenylhydantoin tissues were cultured contained more than twice as much non-dialyzable hydroxyproline than the controls. It was concluded that diphenylhydantoin brought about a reduction in collagen breakdown thus explaining the accumulation of hydroxylated collagen in the tissue.
D002250:Carbon Radioisotopes; D002478:Cells, Cultured; D003094:Collagen / Q000378:metabolism*; D004247:DNA / Q000378:metabolism; D003864:Depression, Chemical; D004827:Epilepsy / Q000188:drug therapy / Q000378:metabolism; D005260:Female; D005881:Gingiva / Q000378:metabolism*; D006801:Humans; D006909:Hydroxyproline / Q000378:metabolism; D010672:Phenytoin / Q000494:pharmacology* / Q000627:therapeutic use; D011392:Proline / Q000378:metabolism
D002250:Carbon Radioisotopes; D010672:Phenytoin; D003094:Collagen; D004247:DNA; D011392:Proline; D006909:Hydroxyproline